Home LiteratureArticle Details
PMID: 19935663 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.

Nature genetics ·Vol. 41 ·No. 12 ·2009-12-00 ·Pages 1290-4

Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M

Abstract

A variant 35 kb upstream of the HLA-C gene (-35C/T) was previously shown to associate with HLA-C mRNA expression level and steady-state plasma HIV RNA levels. We genotyped this variant in 1,698 patients of European ancestry with HIV. Individuals with known seroconversion dates were used for disease progression analysis and those with longitudinal viral load data were used for viral load analysis. We further tested cell surface expression of HLA-C in normal donors using an HLA-C-specific antibody. We show that the -35C allele is a proxy for high HLA-C cell surface expression, and that individuals with high-expressing HLA-C alleles progress more slowly to AIDS and control viremia significantly better than individuals with low HLA-C expressing alleles. These data strongly implicate high HLA-C expression levels in more effective control of HIV-1, potentially through better antigen presentation to cytotoxic T lymphocytes or recognition and killing of infected cells by natural killer cells.

MeSH Terms
Acquired Immunodeficiency Syndrome/genetics,immunology,virology Alleles Genetic Variation Genotype HIV Infections/genetics,immunology,virology HLA-C Antigens/genetics,metabolism Humans Phylogeny RNA, Messenger/metabolism Viral Load/genetics
Chemicals
HLA-C Antigens RNA, Messenger
Authors & Affiliations
22 authors, click to expand affiliations / ORCID
Thomas Rasmi
Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA.
Apps Richard
Qi Ying
Gao Xiaojiang
Male Victoria
O'hUigin Colm
O'Connor Geraldine
Ge Dongliang
Fellay Jacques
Martin Jeffrey N
Margolick Joseph
Goedert James J
Buchbinder Susan
Kirk Gregory D
Martin Maureen P
Telenti Amalio
Deeks Steven G
Walker Bruce D
Goldstein David
McVicar Daniel W
Moffett Ashley
Carrington Mary
References (29)
29 references, click to expand
  1. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.
    J Immunol. 1997 May 1;158(9):4026-8 PMID: 9126959
  2. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
    Nat Genet. 2002 Aug;31(4):429-34 PMID: 12134147
  3. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Science. 1997 Aug 15;277(5328):959-65 PMID: 9252328
  4. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.
    Cell. 1978 May;14(1):9-20 PMID: 667938
  5. Identifiying human MHC supertypes using bioinformatic methods.
    J Immunol. 2004 Apr 1;172(7):4314-23 PMID: 15034046
  6. Population genomics of human gene expression.
    Nat Genet. 2007 Oct;39(10):1217-24 PMID: 17873874
  7. Human NK cell education by inhibitory receptors for MHC class I.
    Immunity. 2006 Aug;25(2):331-42 PMID: 16901727
  8. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
    N Engl J Med. 2001 May 31;344(22):1668-75 PMID: 11386265
  9. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Science. 1998 Dec 4;282(5395):1907-11 PMID: 9836644
  10. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
    Curr Biol. 1998 Jan 1;8(1):1-10 PMID: 9427624
  11. Genome-wide associations of gene expression variation in humans.
    PLoS Genet. 2005 Dec;1(6):e78 PMID: 16362079
  12. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
    J Exp Med. 2006 Mar 20;203(3):633-45 PMID: 16533882
  13. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Nature. 2004 Dec 9;432(7018):769-75 PMID: 15592417
  14. The influence of HLA genotype on AIDS.
    Annu Rev Med. 2003;54:535-51 PMID: 12525683
  15. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies.
    Immunology. 2009 May;127(1):26-39 PMID: 19368562
  16. Licensing of natural killer cells by host major histocompatibility complex class I molecules.
    Nature. 2005 Aug 4;436(7051):709-13 PMID: 16079848
  17. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 1988 Jan;85(1):227-31 PMID: 3257565
  18. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
    Immunity. 1999 Jun;10(6):661-71 PMID: 10403641
  19. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.
    Nat Med. 2005 Dec;11(12):1290-2 PMID: 16288280
  20. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.
    J Virol. 2002 Dec;76(24):12603-10 PMID: 12438586
  21. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.
    J Exp Med. 2007 Nov 26;204(12):3027-36 PMID: 18025129
  22. SYFPEITHI: database for MHC ligands and peptide motifs.
    Immunogenetics. 1999 Nov;50(3-4):213-9 PMID: 10602881
  23. A whole-genome association study of major determinants for host control of HIV-1.
    Science. 2007 Aug 17;317(5840):944-7 PMID: 17641165
  24. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
    PLoS Pathog. 2006 Aug;2(8):e79 PMID: 16933987
  25. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5140-5 PMID: 11309482
  26. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Nat Genet. 2007 Jun;39(6):733-40 PMID: 17496894
  27. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    AIDS. 2003 Dec 5;17(18):2581-91 PMID: 14685052
  28. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.
    Blood. 2005 Jun 1;105(11):4416-23 PMID: 15728129
  29. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.
    Eur J Immunol. 1979 Jul;9(7):536-45 PMID: 91522
Article Info
Journal
Nature genetics
Abbr.
Nat Genet
ISSN
1546-1718
Published
2009-12-00
Pages
1290-4
Language
English
Region
United States
NLM ID
9216904
PMCID
PMC2887091
Subset
IM
Grants
NIDA NIH HHS · R56 DA004334 · United States
NIDA NIH HHS · R01-DA04334 · United States
NIDA NIH HHS · R01 DA004334 · United States
NCRR NIH HHS · UL1 RR024131 · United States
Intramural NIH HHS · United States
NIAID NIH HHS · P30 AI027763 · United States
NIDA NIH HHS · R01 DA012568 · United States
CCR NIH HHS · HHSN261200800001C · United States
NCI NIH HHS · N02CP55504 · United States
NIDA NIH HHS · R01-DA12568 · United States
NIAID NIH HHS · P30 AI27763 · United States
NCI NIH HHS · HHSN261200800001E · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com